Business
For Early Success in Cannabis Look Outside the Box
For Early Success in Cannabis Look Outside the Box.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n\n\n\nFor Early Success in Cannabis Look Outside the Box\n\n\n\n\n\nFor Early Success in Cannabis Look Outside the Box\nPR Newswire\nLOS ANGELES, October 11, 2017\n\n\n\nLOS ANGELES, October 11, 2017 /PRNewswire/ --\n\n - USA News Group News Commentary \n\nUSA News Group -To capture big gains prior to wide adoption and legalization in the marijuana space may require thinking a little outside the box or perhaps outside your geographical comfort zone.\n\nBut it could certainly pay off. Many top pot stocks are on the rise and up hundreds of percent as the cannabis market is booming.\n\nCompanies generating wide interest in this category include Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF) MedReleaf (OTC: MEDFF), GW Pharmaceuticals (NASDAQ: GWPH) and Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF)\n\nThe first obvious move is to focus on Canadian companies. While they operate mostly outside the U.S., many trade on U.S. exchanges.\n\nCanada has already declared it is committed to legalize recreational sales of marijuana by July 2018 and its medical application has been legal there since 2010.\n\nCanada's enormous projected demand for quality cannabis also signals a massive need for specialized testing, control quality and research. \n\nHere Abattis Bioceuticals Corp. (CSE: ATT.CN) (OTCQB: ATTBF) is a standout that operates testing and research facilities licensed expressly for this purpose. ATT is setting up to become one of the country's pre-eminent cannabis testing, R&D and extraction technology companies.\n\nThe Largest Licensed Producer in Canada is Canopy Growth Inc. (TSX: WEED.TO) (OTC: TWMJF) with a CDN $1 Billion Market Cap., followed by, MedReleaf (OTC: MEDFF), the second largest supplier. MedReleaf's value is up 40% over the last four months alone.\n\nBoth companies are well positioned to service the Canadian market and are entering global markets for cannabis.\n\nAnother tact that could produce major returns in this sector is Pharmaceutical companies who are employing marijuana and its derivatives like GW Pharmaceuticals (NASDAQ: GWPH). This large UK-based pharma is looking to use cannabinoids from the cannabis plant to effect positive biologic changes.\n\nALL MARKETS GROWING \n\nIf there remained any doubt as to whether the marijuana markets are flourishing, just last week, Canada's most heavily pop...